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Background: The edge response following implantation of the ABSORB BVS was investigated using intravascular radiofrequency (IVUS-RF) analyses 
of the proximal (prox) & distal edges.
Methods: The ABSORB Cohort B trial was divided into B1 (n=45) and B2 (n=56) subgroups. The 5mm prox & distal edges to the implanted ABSORB 
BVS, were investigated at either 6-months (B1) or 1-year (B2) with IVUS-RF imaging.
Results: The percentage % change (median [IQR]) of the vessel cross-sectional area (CSA), lumen CSA & plaque CSA at the 5mm prox edge 
segment demonstrated modest constrictive remodeling at 6-months [vessel CSA: -1.80% [-3.18; 1.30], (p<0.05)], with a tendency to regress at 
1-year [vessel CSA: -1.53% [-7.74; 2.48], (p=0.06)]. The % change of the fibrotic (F) & fibrofatty (FF) tissue areas were not significant at both time 
points. At the 5mm distal edge, a significant increase in the FF tissue of 43.32% [-19.90; 244.28], (p<0.05)], 1- year post-implantation was evident. 
The changes in calcified tissue (DC) at both scaffold edges need to be interpreted with caution since the polymeric struts of the device are detected 
as “pseudo” DC structures with IVUS-RF imaging. (Figure 1)
Conclusions: The vascular response up to 1-year following implantation of the ABSORB BVS demonstrated some degree of prox edge constrictive 
remodeling without significant plaque changes. At the distal edge, a significant increase in the FF tissue was observed resulting in a nonsignificant 
plaque progression and adaptive expansive remodeling.
